Engitix Therapeutics
Decoding the ECM space to unlock unprecedented therapies for chronic diseases
63 employees · est. 2016 · London, United Kingdom
HemoShear Therapeutics
Developing new treatments for rare metabolic disorders
27 employees · est. 2008 · Charlottesville, United Stat...
HemoShear Therapeutics is the older company (2016 vs 2008); Engitix Therapeutics is the larger of the two.
1 signal in the last 90 days
Side-by-Side Comparison
| Metric | Engitix Therapeutics | HemoShear Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2016 | 2008 older |
| Headquarters | ||
| Headquarters | London, United Kingdom | Charlottesville, United States |
| Employees | ||
| Employees | 63 larger | 27 |
| Industry | ||
| Industry | Biotechnology, Health Care, Life Sciences | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Series A | Debt Financing |
| Total Funding | ||
| Total Funding | $59.00M | $54.95M |
| Funding Rounds | ||
| Funding Rounds | 2 | 8 |
| Services | ||
| Services | ECM Platform Development, Disease Modeling, Therapeutic Discovery, Research Collaborations | Not tracked yet |
| Target Customers | ||
| Target Customers | Pharmaceutical Companies, Biotech Firms, Medical Researchers, Healthcare Providers | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Human Extracellular Matrix, Discovery Platform, Fibrosis Therapeutics, Solid Tumor Therapy, In Vitro Models, Drug Target Identification, Biomarker Discovery, Mechanism Of Action Study, Liver Disease Research, Regenerative Medicine, Drug Profiling, Bioartificial Liver Devices, Organ Decellularisation, Tissue Engineering, 3D Spheroids | Drug Discovery, Metabolic Disorders, Rare Diseases, Human Disease Models, Tissue Engineering, Pharmaceutical Partnerships, Clinical Success, Genetic Defects, Liver Diseases, Treatment Development |
| Website | ||
| Website | engitix.com | hemoshear.com |
About Engitix Therapeutics
Engitix Therapeutics, founded in 2016 and headquartered in the United Kingdom, is at the forefront of the Biotechnology, Health Care, and Life Sciences industries. The company aims to transform therapy development for chronic diseases through its pioneering extracellular matrix (ECM)-based discovery...
About HemoShear Therapeutics
HemoShear Therapeutics is a biotechnology company with a focus on developing new treatments for rare metabolic disorders. Established in 2008, the company utilizes a proprietary technology that allows them to recapitulate diseases using tissue from livers of children born with genetic defects. This...
We will tell you when either one moves
BounceWatch watches Engitix Therapeutics and HemoShear Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Engitix Therapeutics and HemoShear Therapeutics — by email.
Frequently Asked Questions
Compare Engitix Therapeutics with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Engitix Therapeutics on 29 Apr 2026, and HemoShear Therapeutics on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.